Literature DB >> 15684425

Phosphorylation of Ser28 in histone H3 mediated by mixed lineage kinase-like mitogen-activated protein triple kinase alpha.

Hong Seok Choi1, Bu Young Choi, Yong-Yeon Cho, Feng Zhu, Ann M Bode, Zigang Dong.   

Abstract

The mitogen-activated protein kinase cascades elicit modification of chromatin proteins such as histone H3 by phosphorylation concomitant with gene activation. Here, we demonstrate for the first time that the mixed lineage kinase-like mitogen-activated protein triple kinase (MLTK)-alpha phosphorylates histone H3 at Ser28. MLTK-alpha but neither a kinase-negative mutant of MLTK-alpha nor MLTK-beta interacted with and phosphorylated histone H3 in vivo and in vitro. When overexpressed in 293T or JB6 Cl41 cells, MLTK-alpha phosphorylated histone H3 at Ser28 but not at Ser10. The interaction between MLTK-alpha and histone H3 was enhanced by stimulation with ultraviolet B light (UVB) or epidermal growth factor (EGF), which resulted in the accumulation of MLTK-alpha in the nucleus. UVB- or EGF-induced phosphorylation of histone H3 at Ser28 was not affected by PD 98059, a MEK inhibitor, or SB 202190, a p38 kinase inhibitor, in MLTK-alpha-overexpressing JB6 Cl41 cells. Significantly, UVB- or EGF-induced phosphorylation of histone H3 at Ser28 was blocked by small interfering RNA of MLTK-alpha. The inhibition of histone H3 phosphorylation at Ser28 in the MLTK-alpha knock-down JB6 Cl41 cells was not due to a defect in mitogen- and stress-activated protein kinase 1 or 90-kDa ribosomal S6 kinase (p90RSK) activity. In summary, these results illustrate that MLTK-alpha plays a key role in the UVB- and EGF-induced phosphorylation of histone H3 at Ser28, suggesting that MLTK-alpha might be a new histone H3 kinase at the level of mitogen-activated protein kinase kinase kinases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15684425     DOI: 10.1074/jbc.M410521200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Signaling coupled epigenomic regulation of gene expression.

Authors:  R Kumar; S Deivendran; T R Santhoshkumar; M R Pillai
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

Review 2.  Histone phosphorylation: a chromatin modification involved in diverse nuclear events.

Authors:  Dorine Rossetto; Nikita Avvakumov; Jacques Côté
Journal:  Epigenetics       Date:  2012-09-04       Impact factor: 4.528

3.  Histone H3 Ser10 phosphorylation-independent function of Snf1 and Reg1 proteins rescues a gcn5- mutant in HIS3 expression.

Authors:  Yang Liu; Xinjing Xu; Soumya Singh-Rodriguez; Yan Zhao; Min-Hao Kuo
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

4.  Selective repression of low-density lipoprotein receptor expression by SP600125: coupling of histone H3-Ser10 phosphorylation and Sp1 occupancy.

Authors:  Wei Huang; Sanjay Batra; Sasi Korrapati; V Mishra; Kamal D Mehta
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

Review 5.  Chromatin-modifying enzymes as therapeutic targets--Part 2.

Authors:  Brian R Keppler; Trevor K Archer
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

6.  The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer.

Authors:  C Rey; B Faustin; I Mahouche; R Ruggieri; C Brulard; F Ichas; I Soubeyran; L Lartigue; F De Giorgi
Journal:  Oncogene       Date:  2015-11-02       Impact factor: 9.867

7.  An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth.

Authors:  Adam S Adler; Mark L McCleland; Sharon Yee; Murat Yaylaoglu; Sofia Hussain; Ely Cosino; Gabriel Quinones; Zora Modrusan; Somasekar Seshagiri; Eric Torres; Vivek S Chopra; Benjamin Haley; Zemin Zhang; Elizabeth M Blackwood; Mallika Singh; Melissa Junttila; Jean-Philippe Stephan; Jinfeng Liu; Gregoire Pau; Eric R Fearon; Zhaoshi Jiang; Ron Firestein
Journal:  Genes Dev       Date:  2014-05-01       Impact factor: 11.361

8.  The Chromatin Modifier MSK1/2 Suppresses Endocrine Cell Fates during Mouse Pancreatic Development.

Authors:  Neha Bhat; Jeehye Park; Huda Y Zoghbi; J Simon C Arthur; Kenneth S Zaret
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

9.  Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer.

Authors:  Jinfeng Liu; Mark McCleland; Eric W Stawiski; Florian Gnad; Oleg Mayba; Peter M Haverty; Steffen Durinck; Ying-Jiun Chen; Christiaan Klijn; Suchit Jhunjhunwala; Michael Lawrence; Hanbin Liu; Yinan Wan; Vivek Chopra; Murat B Yaylaoglu; Wenlin Yuan; Connie Ha; Houston N Gilbert; Jens Reeder; Gregoire Pau; Jeremy Stinson; Howard M Stern; Gerard Manning; Thomas D Wu; Richard M Neve; Frederic J de Sauvage; Zora Modrusan; Somasekar Seshagiri; Ron Firestein; Zemin Zhang
Journal:  Nat Commun       Date:  2014-05-08       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.